About Range Bio
Range Bio is a company based in San Carlos (United States) founded in 2022 by Brandon Wilson and Nicolo Maganzini. Range Bio has raised $5.2 million across 1 funding round from investors including Pear VC, Artis Ventures and Page One Ventures. Range Bio offers products and services including Translational Proteomics Solution. Range Bio operates in a competitive market with competitors including Atrys, OrigiMed, Nanopath, N-of-One and Coral Genomics, among others.
- Headquarter San Carlos, United States
- Founders Brandon Wilson, Nicolo Maganzini
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Range Biotechnologies Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.2 M (USD)
in 1 rounds
-
Latest Funding Round
$5.2 M (USD), Seed
Jun 12, 2023
-
Investors
Pear VC
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Range Bio
Range Bio offers a comprehensive portfolio of products and services, including Translational Proteomics Solution.
End-to-end platform for protein quantification and biomarker discovery
People of Range Bio
Unlock access to complete
Funding Insights of Range Bio
Range Bio has successfully raised a total of $5.2M through 1 strategic funding round. The most recent funding activity was a Seed round of $5.2 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Range Bio
Range Bio has secured backing from 7 investors, including venture fund investors. Prominent investors backing the company include Pear VC, Artis Ventures and Page One Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are invested in by Artis Ventures.
|
Locked | Locked | Locked | |
|
Seed & early stage VC firm investing the US
|
Locked | Locked | Locked | |
|
Early-stage startups are funded by the venture capital firm.
|
Locked | Locked | Locked |
Investor details for Range Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Range Bio
Investment portfolio details for Range Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Range Bio
Detailed financials for Range Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Range Bio Comparisons
Peer comparison for Range Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Range Bio
Range Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Atrys, OrigiMed, Nanopath, N-of-One and Coral Genomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of diagnostic and therapeutic services catering to cancer
|
|
| Locked | Locked | Locked |
Genetic sequencing is utilized for personalized cancer diagnostics and counseling.
|
|
| Locked | Locked | Locked |
Point-of-care molecular diagnostics for women's health are provided by Nanopath.
|
|
| Locked | Locked | Locked |
Molecular profiles are analyzed for clinical decision support in oncology.
|
|
| Locked | Locked | Locked |
Genomic data is analyzed for personalized drug development optimization.
|
Detailed competitors of Range Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Range Bio
Complete news archive for Range Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Range Bio
Range Bio was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Range Bio is headquartered in San Carlos, United States. It is registered at San Carlos, California, United States.
Brandon Wilson is the current CEO of Range Bio. They have also founded this company.
Range Bio is a funded company, having raised a total of $5.2M across 1 funding round to date.
Provider of solutions for health monitoring based on translational proteomics. It develops tools that capture the molecular state of individuals to prevent disease and improve health.
Range Bio offers Translational Proteomics Solution.
Range Bio has 7 investors. Key investors include Pear VC, Artis Ventures, Page One Ventures, Civilization Ventures, and Pillar VC.